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Introduction
Eosinophilic gastroenteritis (EGE) is an uncommon gas-
trointestinal disorder. The manifestations of EGE are
varied and steroids are the mainstay of treatment. To
our knowledge we present the first case of successful
treatment of pediatric EGE with both budesonide in oral
suspension and enteric-coated budesonide.
Case report
A 16 year old female with a chronic history of mild
abdominal discomfort presented with acute severe
abdominal pain. Her absolute eosinophil count was ele-
vated as was her total IgE. Skin testing, serology and
other bloodwork were negative. Computed tomography
scan of abdomen and pelvis showed diffuse thickening of
the duodenum. Histopathological studies of gastric and
duodenal biopsies revealed heavy eosinophilic infiltration.
She had improvement on prednisone however the
patient’s symptoms relapsed after discontinuing. Her
symptoms were then controlled on a daily dose of 11 mg
of oral budesonide in two different formulations. 2 mg of
daily budesonide was given in the form of sweetened oral
suspension and 9 mg of daily budesonide was given in
the form of enteric coated (EC) budesonide oral tablets
The patient reported significant improvement of symp-
toms within 5 days of starting the budesonide combina-
tion. The patient continued budesonide treatment for
one month. She has been asymptomatic to 13 months
following treatment with follow up endoscopy revealing
full resolution of eosinophilic infiltration.
Conclusion
Oral budesonide can be useful in the treatment of EGE.
We suggest that careful selection of budesonide formu-
lations for EGE treatment is important to ensure correct
drug delivery to the affected gut.
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